甜味溶液减轻新生儿操作性疼痛:一项荟萃分析
结果显示,自2002年第五项试验起,甜味溶液较安慰剂显著缩短平均哭泣时间(-27秒,95%CI -51至-4),最终合并结果为-23秒(95%CI -29至-18);疼痛评分自第二项试验起即支持甜味溶液(0.5,95%CI -1至-0.1),最终标准化均数差为-0.9(95%CI -1.1至-0.7)。作者指出甜味镇痛证据早已存在,未来研究应选择更符合伦理的对照组。
要点
- 甜味溶液可显著缩短新生儿操作性疼痛所致哭泣时间,最终合并效应为-23秒。
- 甜味溶液可显著降低新生儿操作性疼痛评分,最终标准化均数差为-0.9。
- 自早期试验起甜味镇痛证据即存在,后续安慰剂对照试验的伦理必要性存疑。
核心结论
- 甜味溶液对新生儿操作性疼痛具有镇痛效果,表现为哭泣时间缩短和疼痛评分降低。
- 甜味镇痛证据自首批试验即已存在,但安慰剂/无治疗对照试验仍在继续开展。
研究设计与样本
- 数据来源包括2项关于新生儿甜味溶液的系統评价,以及截至2015年CINAHL、Medline、Embase和psychINFO的检索。
- 由两名作者筛选研究、进行偏倚风险评估并提取行为学结局数据,采用随机效应模型进行累积荟萃分析。
主要发现
- 哭泣时间累积荟萃分析纳入29项试验(1175名婴儿),自2002年第五项试验起甜味溶液较安慰剂显著缩短平均哭泣时间(-27秒,95%CI -51至-4)。
- 哭泣时间最终累积荟萃分析结果为-23秒,支持甜味溶液(95%CI -29至-18)。
- 疼痛评分累积荟萃分析纳入50项试验(3341名婴儿),自第二项试验起结果即支持甜味溶液(0.5,95%CI -1至-0.1)。
- 疼痛评分最终结果为标准化均数差-0.9,支持甜味溶液(95%CI -1.1至-0.7)。
临床怎么用
- 新生儿操作性疼痛管理可考虑使用甜味溶液,现有证据支持其缩短哭泣时间和降低疼痛评分。
- 开展新生儿疼痛研究时应选择更符合伦理的对照组,而非继续使用安慰剂/无治疗对照。
局限性
- 许多研究的数据无法使用或获取,未能纳入累积荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Abundant evidence of sweet taste analgesia in neonates exists, yet placebo-controlled trials continue to be conducted. OBJECTIVE: To review all trials evaluating sweet solutions for analgesia in neonates and to conduct cumulative meta-analyses (CMAs) on behavioral pain outcomes. DATA SOURCES: (1) Data from 2 systematic reviews of sweet solutions for newborns; (2) searches ending 2015 of CINAHL, Medline, Embase, and psychINFO. DATA EXTRACTION AND ANALYSIS: Two authors screened studies for inclusion, conducted risk-of-bias ratings, and extracted behavioral outcome data for CMAs. CMA was performed using random effects meta-analysis. RESULTS: One hundred and sixty-eight studies were included; 148 (88%) included placebo/no-treatment arms. CMA for crying time included 29 trials (1175 infants). From the fifth trial in 2002, there was a statistically significant reduction in mean cry time for sweet solutions compared with placebo (-27 seconds, 95% confidence interval [CI] -51 to -4). By the final trial, CMA was -23 seconds in favor of sweet solutions (95% CI -29 to -18). CMA for pain scores included 50 trials (3341 infants). Results were in favor of sweet solutions from the second trial (0.5, 95% CI -1 to -0.1). Final results showed a standardized mean difference of -0.9 (95% CI -1.1 to -0.7). LIMITATIONS: We were unable to use or obtain data from many studies to include in the CMA. CONCLUSIONS: Evidence of sweet taste analgesia in neonates has existed since the first published trials, yet placebo/no-treatment, controlled trials have continued to be conducted. Future neonatal pain studies need to select more ethically responsible control groups.
引用
- Harrison D, Larocque C, Bueno M, et al. Sweet Solutions to Reduce Procedural Pain in Neonates: A Meta-analysis. Pediatrics. 2016. PMID: 27986905. doi:10.1542/peds.2016-0955
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。